Bath & Body Works (NYSE:BBWI) Releases Q2 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI - Get Free Report) updated its second quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.330-0.380 for the period, compared to the consensus earnings per share estimate of 0.420. The company issued revenue guidance of -, compared to the consensus revenue estimate of $1.6 billion.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on BBWI. UBS Group increased their target price on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Morgan Stanley cut their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 6th. Raymond James cut their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research report on Thursday, April 17th. JPMorgan Chase & Co. increased their target price on Bath & Body Works from $41.00 to $43.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. Finally, Robert W. Baird increased their target price on Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a research report on Friday, February 28th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.00.

Bath & Body Works Stock Down 1.5%

Shares of Bath & Body Works stock traded down $0.42 during trading hours on Friday, hitting $28.16. 6,154,657 shares of the company's stock traded hands, compared to its average volume of 4,999,252. The stock has a 50 day simple moving average of $30.07 and a 200-day simple moving average of $33.94. The company has a market cap of $6.00 billion, a PE ratio of 6.87, a PEG ratio of 0.92 and a beta of 1.87. Bath & Body Works has a twelve month low of $24.96 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company's revenue was up 2.9% on a year-over-year basis. During the same period last year, the firm earned $0.38 earnings per share. As a group, equities research analysts predict that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 2.84%. Bath & Body Works's dividend payout ratio is presently 21.33%.

Bath & Body Works announced that its Board of Directors has authorized a stock repurchase plan on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board of directors believes its shares are undervalued.

Hedge Funds Weigh In On Bath & Body Works

Hedge funds have recently bought and sold shares of the company. Geneos Wealth Management Inc. grew its stake in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Intech Investment Management LLC acquired a new position in Bath & Body Works in the first quarter worth about $1,155,000. Royal Bank of Canada grew its stake in Bath & Body Works by 92.8% in the first quarter. Royal Bank of Canada now owns 59,877 shares of the company's stock worth $1,815,000 after purchasing an additional 28,815 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Bath & Body Works by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company's stock worth $17,063,000 after purchasing an additional 36,684 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in Bath & Body Works by 15.7% in the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company's stock worth $19,586,000 after purchasing an additional 87,529 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.